Reports Q2 revenue $116.6M, consensus $105.43M. Graham Purdy, President and CEO, commented, “Our consolidated second quarter results were better than expected. Modern Oral sales were $30.1M, increasing by 35% versus prior quarter and up 651% against the prior year. Stoker’s MST and looseleaf showed modest gains with Zig-Zag flat sequentially.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPB:
- Avis Budget downgraded, Sprouts upgraded: Wall Street’s top analyst calls
- Turning Point Brands initiated with a Hold at Needham
- Turning Point Brands: Promising Growth in Nicotine Pouches and Diverse Revenue Streams, But Current Valuation Justifies Hold Rating
- FRE Nicotine Pouches partners with PBR for ‘Unleash The Beast’